- Company
-
Location:
Switzerland, - Bern
- Company
SR Score
0
SR Web
0
Delenex Therapeutics is engaged in developing therapeutic antibody fragments for diseases with high unmet needs.
Acquired by Cell Medica on July 12, 2016
Website:
https://www.delenex.com
Founded: January 01, 2009
Social: